| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Added value of dedicated axillary hybrid 18F-FDG PET/MRI for improved axillary nodal staging in clinically node-positive breast cancer patients: a feasibility study
|
Nijnatten, Thiemo J. A. van
|
|
2017
|
45 |
Suppl 1 |
p. 179-186
|
artikel
|
| 2 |
Amyloid involvement in subcortical regions predicts cognitive decline
|
Cho, Soo Hyun
|
|
2018
|
45 |
Suppl 1 |
p. 2368-2376
|
artikel
|
| 3 |
A risk stratification model for nodal peripheral T-cell lymphomas based on the NCCN-IPI and posttreatment Deauville score
|
Yhim, Ho-Young
|
|
2018
|
45 |
Suppl 1 |
p. 2274-2284
|
artikel
|
| 4 |
A score combining baseline neutrophilia and primary tumor SUVpeak measured from FDG PET is associated with outcome in locally advanced cervical cancer
|
Schernberg, Antoine
|
|
2017
|
45 |
Suppl 1 |
p. 187-195
|
artikel
|
| 5 |
Assessing FDG-PET diagnostic accuracy studies to develop recommendations for clinical use in dementia
|
Boccardi, Marina
|
|
2018
|
45 |
Suppl 1 |
p. 1470-1486
|
artikel
|
| 6 |
Assessment of alteration in liver 18F–FDG uptake due to steatosis in lymphoma patients and its impact on the Deauville score
|
Salomon, Thibault
|
|
2017
|
45 |
Suppl 1 |
p. 941-950
|
artikel
|
| 7 |
Automated SPECT analysis compared with expert visual scoring for the detection of FFR-defined coronary artery disease
|
Driessen, R. S.
|
|
2018
|
45 |
Suppl 1 |
p. 1091-1100
|
artikel
|
| 8 |
Cardiac denervation evidenced by MIBG occurs earlier than amyloid deposits detection by diphosphonate scintigraphy in TTR mutation carriers
|
Piekarski, Eve
|
|
2018
|
45 |
Suppl 1 |
p. 1108-1118
|
artikel
|
| 9 |
Changes in multimodality functional imaging parameters early during chemoradiation predict treatment response in patients with locally advanced head and neck cancer
|
Wong, Kee H.
|
|
2017
|
45 |
Suppl 1 |
p. 759-767
|
artikel
|
| 10 |
Clinical translation of [18F]ICMT-11 for measuring chemotherapy-induced caspase 3/7 activation in breast and lung cancer
|
Dubash, S. R.
|
|
2018
|
45 |
Suppl 1 |
p. 2285-2299
|
artikel
|
| 11 |
Clinical utility of FDG PET in Parkinson’s disease and atypical parkinsonism associated with dementia
|
Walker, Zuzana
|
|
2018
|
45 |
Suppl 1 |
p. 1534-1545
|
artikel
|
| 12 |
Combination of baseline FDG PET/CT total metabolic tumour volume and gene expression profile have a robust predictive value in patients with diffuse large B-cell lymphoma
|
Toledano, Mathieu Nessim
|
|
2018
|
45 |
Suppl 1 |
p. 680-688
|
artikel
|
| 13 |
Combined evaluation of regional coronary artery calcium and myocardial perfusion by 82Rb PET/CT in the identification of obstructive coronary artery disease
|
Zampella, Emilia
|
|
2018
|
45 |
Suppl 1 |
p. 521-529
|
artikel
|
| 14 |
Combined model-based and patient-specific dosimetry for 18F-DCFPyL, a PSMA-targeted PET agent
|
Plyku, Donika
|
|
2018
|
45 |
Suppl 1 |
p. 989-998
|
artikel
|
| 15 |
Comparison of 18F–FDG PET/MRI and MRI alone for whole-body staging and potential impact on therapeutic management of women with suspected recurrent pelvic cancer: a follow-up study
|
Sawicki, Lino M.
|
|
2017
|
45 |
Suppl 1 |
p. 622-629
|
artikel
|
| 16 |
Comparison of glucagon-like peptide-1 receptor (GLP-1R) PET/CT, SPECT/CT and 3T MRI for the localisation of occult insulinomas: evaluation of diagnostic accuracy in a prospective crossover imaging study
|
Antwi, Kwadwo
|
|
2018
|
45 |
Suppl 1 |
p. 2318-2327
|
artikel
|
| 17 |
Correction to: Dosimetry in clinical radionuclide therapy: the devil is in the detail
|
Giammarile, Francesco
|
|
2018
|
45 |
Suppl 1 |
p. 676
|
artikel
|
| 18 |
Could short thyroid hormone withdrawal be an effective strategy for radioiodine remnant ablation in differentiated thyroid cancer patients?
|
Piccardo, Arnoldo
|
|
2018
|
45 |
Suppl 1 |
p. 1218-1223
|
artikel
|
| 19 |
Diagnostic utility of 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) in asymptomatic subjects at increased risk for Alzheimer’s disease
|
Drzezga, Alexander
|
|
2018
|
45 |
Suppl 1 |
p. 1487-1496
|
artikel
|
| 20 |
Dual-time point 18F-FDG PET/CT for the staging of oesophageal cancer: the best diagnostic performance by retention index for N-staging in non-calcified lymph nodes
|
Park, Sohyun
|
|
2018
|
45 |
Suppl 1 |
p. 1317-1328
|
artikel
|
| 21 |
Effect of CRP value on 18F–FDG PET vascular positivity in Takayasu arteritis: a systematic review and per-patient based meta-analysis
|
Gomez, Léa
|
|
2017
|
45 |
Suppl 1 |
p. 575-581
|
artikel
|
| 22 |
F18-choline PET/CT guided surgery in primary hyperparathyroidism when ultrasound and MIBI SPECT/CT are negative or inconclusive: the APACH1 study
|
Quak, Elske
|
|
2017
|
45 |
Suppl 1 |
p. 658-666
|
artikel
|
| 23 |
FDG PET/CT radiomics for predicting the outcome of locally advanced rectal cancer
|
Lovinfosse, Pierre
|
|
2017
|
45 |
Suppl 1 |
p. 365-375
|
artikel
|
| 24 |
18F-DOPA PET/CT and 68Ga-DOTANOC PET/CT scans as diagnostic tools in focal congenital hyperinsulinism: a blinded evaluation
|
Christiansen, Charlotte Dahl
|
|
2017
|
45 |
Suppl 1 |
p. 250-261
|
artikel
|
| 25 |
18F-FDG PET and high-resolution MRI co-registration for pre-surgical evaluation of patients with conventional MRI-negative refractory extra-temporal lobe epilepsy
|
Ding, Yao
|
|
2018
|
45 |
Suppl 1 |
p. 1567-1572
|
artikel
|
| 26 |
18F-Fluorocholine PET/CT in the assessment of primary hyperparathyroidism compared with 99mTc-MIBI or 99mTc-tetrofosmin SPECT/CT: a prospective dual-centre study in 100 patients
|
Beheshti, Mohsen
|
|
2018
|
45 |
Suppl 1 |
p. 1762-1771
|
artikel
|
| 27 |
From fixed activities to personalized treatments in radionuclide therapy: lost in translation?
|
Flux, G. D.
|
|
2017
|
45 |
Suppl 1 |
p. 152-154
|
artikel
|
| 28 |
68Ga-PSMA 11 ligand PET imaging in patients with biochemical recurrence after radical prostatectomy – diagnostic performance and impact on therapeutic decision-making
|
Grubmüller, B.
|
|
2017
|
45 |
Suppl 1 |
p. 235-242
|
artikel
|
| 29 |
68Ga-PSMA-11 PET/CT in primary staging of prostate carcinoma: preliminary results on differences between black and white South-Africans
|
Sathekge, Mike
|
|
2017
|
45 |
Suppl 1 |
p. 226-234
|
artikel
|
| 30 |
How much primary tumor metabolic volume reduction is required to improve outcome in stage III NSCLC after chemoradiotherapy? A single-centre experience
|
Roengvoraphoj, Olarn
|
|
2018
|
45 |
Suppl 1 |
p. 2103-2109
|
artikel
|
| 31 |
Hypermetabolism in the cerebellum and brainstem and cortical hypometabolism are independently associated with cognitive impairment in Parkinson’s disease
|
Blum, Dominik
|
|
2018
|
45 |
Suppl 1 |
p. 2387-2395
|
artikel
|
| 32 |
ImmunoPET imaging of CD38 in murine lymphoma models using 89Zr-labeled daratumumab
|
Kang, Lei
|
|
2018
|
45 |
Suppl 1 |
p. 1372-1381
|
artikel
|
| 33 |
Impact of improved attenuation correction featuring a bone atlas and truncation correction on PET quantification in whole-body PET/MR
|
Oehmigen, Mark
|
|
2017
|
45 |
Suppl 1 |
p. 642-653
|
artikel
|
| 34 |
Improving quality of life in patients with pancreatic neuroendocrine tumor following peptide receptor radionuclide therapy assessed by EORTC QLQ-C30
|
Marinova, Milka
|
|
2017
|
45 |
Suppl 1 |
p. 38-46
|
artikel
|
| 35 |
Incidental identification of osteoid osteoma by 68Ga-PSMA PET/CT
|
Castello, Angelo
|
|
2017
|
45 |
Suppl 1 |
p. 509-510
|
artikel
|
| 36 |
Increased evidence for the prognostic value of FDG uptake on late-treatment PET in non-tumour-affected oesophagus in irradiated patients with oesophageal carcinoma
|
Li, Yimin
|
|
2018
|
45 |
Suppl 1 |
p. 1752-1761
|
artikel
|
| 37 |
Is it time to change our vision of tumor metabolism prior to immunotherapy?
|
Grizzi, Fabio
|
|
2018
|
45 |
Suppl 1 |
p. 1072-1075
|
artikel
|
| 38 |
Life is not black and white, nor just Shades of Gray
|
Beyer, T.
|
|
2018
|
45 |
Suppl 1 |
p. 816-821
|
artikel
|
| 39 |
Liver metastases from prostate cancer at 11C-Choline PET/CT: a multicenter, retrospective analysis
|
Ghedini, Pietro
|
|
2017
|
45 |
Suppl 1 |
p. 751-758
|
artikel
|
| 40 |
Local and whole-body staging in patients with primary breast cancer: a comparison of one-step to two-step staging utilizing 18F-FDG-PET/MRI
|
Kirchner, Julian
|
|
2018
|
45 |
Suppl 1 |
p. 2328-2337
|
artikel
|
| 41 |
Longitudinal PET imaging of tumor hypoxia during the course of radiotherapy
|
Stieb, Sonja
|
|
2018
|
45 |
Suppl 1 |
p. 2201-2217
|
artikel
|
| 42 |
Low baseline and subsequent higher aortic abdominal aneurysm FDG uptake are associated with poor sac shrinkage post endovascular repair
|
Marie, Pierre-Yves
|
|
2017
|
45 |
Suppl 1 |
p. 549-557
|
artikel
|
| 43 |
Metabolic activity by 18F–FDG-PET/CT is predictive of early response after nivolumab in previously treated NSCLC
|
Kaira, Kyoichi
|
|
2017
|
45 |
Suppl 1 |
p. 56-66
|
artikel
|
| 44 |
Patterns of bone tracer uptake on SPECT-CT in symptomatic and asymptomatic patients with primary total hip arthroplasty
|
Schweizer, Thierry
|
|
2017
|
45 |
Suppl 1 |
p. 283-291
|
artikel
|
| 45 |
Peptide receptor radionuclide therapy (PRRT) in European Neuroendocrine Tumour Society (ENETS) grade 3 (G3) neuroendocrine neoplasia (NEN) - a single-institution retrospective analysis
|
Thang, Sue Ping
|
|
2017
|
45 |
Suppl 1 |
p. 262-277
|
artikel
|
| 46 |
Performance of FDG-PET/CT in solitary pulmonary nodule based on pre-test likelihood of malignancy: results from the ITALIAN retrospective multicenter trial
|
Evangelista, Laura
|
|
2018
|
45 |
Suppl 1 |
p. 1898-1907
|
artikel
|
| 47 |
Preclinical evaluation of an 18F-trifluoroborate methionine derivative for glioma imaging
|
Yang, Xiangyu
|
|
2017
|
45 |
Suppl 1 |
p. 585-592
|
artikel
|
| 48 |
Prediction of functional recovery after primary PCI using the estimate of myocardial salvage in gated SPECT early after acute myocardial infarction
|
Calabretta, Raffaella
|
|
2017
|
45 |
Suppl 1 |
p. 530-537
|
artikel
|
| 49 |
Pre-dosing with lilotomab prior to therapy with 177Lu-lilotomab satetraxetan significantly increases the ratio of tumor to red marrow absorbed dose in non-Hodgkin lymphoma patients
|
Stokke, Caroline
|
|
2018
|
45 |
Suppl 1 |
p. 1233-1241
|
artikel
|
| 50 |
Prognostic role of serial quantitative evaluation of 18F-fluorodeoxyglucose uptake by PET/CT in patients with cardiac sarcoidosis presenting with ventricular tachycardia
|
Muser, Daniele
|
|
2018
|
45 |
Suppl 1 |
p. 1394-1404
|
artikel
|
| 51 |
Prognostic value of normal stress myocardial perfusion imaging and ventricular function in Japanese patients with chronic kidney disease: a study based on the J-ACCESS-3 database
|
Matsuo, Shinro
|
|
2018
|
45 |
Suppl 1 |
p. 1101-1107
|
artikel
|
| 52 |
Prognostic value of posttreatment 18F-FDG PET/CT and predictors of metabolic response to therapy in patients with locally advanced cervical cancer treated with concomitant chemoradiation therapy: an analysis of intensity- and volume-based PET parameters
|
Lima, Giacomo Maria
|
|
2018
|
45 |
Suppl 1 |
p. 2139-2146
|
artikel
|
| 53 |
Prolonged survival in secondary glioblastoma following local injection of targeted alpha therapy with 213Bi-substance P analogue
|
Krolicki, Leszek
|
|
2018
|
45 |
Suppl 1 |
p. 1636-1644
|
artikel
|
| 54 |
Prospective evaluation of 18F-FACBC PET/CT and PET/MRI versus multiparametric MRI in intermediate- to high-risk prostate cancer patients (FLUCIPRO trial)
|
Jambor, Ivan
|
|
2017
|
45 |
Suppl 1 |
p. 355-364
|
artikel
|
| 55 |
Prospective observational study of 177Lu-DOTA-octreotate therapy in 200 patients with advanced metastasized neuroendocrine tumours (NETs): feasibility and impact of a dosimetry-guided study protocol on outcome and toxicity
|
Garske-Román, Ulrike
|
|
2018
|
45 |
Suppl 1 |
p. 970-988
|
artikel
|
| 56 |
PSA-stratified detection rates for [68Ga]THP-PSMA, a novel probe for rapid kit-based 68Ga-labeling and PET imaging, in patients with biochemical recurrence after primary therapy for prostate cancer
|
Derlin, Thorsten
|
|
2018
|
45 |
Suppl 1 |
p. 913-922
|
artikel
|
| 57 |
Quantitative evaluation of tau PET tracers 18F-THK5351 and 18F-AV-1451 in Alzheimer’s disease with standardized uptake value peak-alignment (SUVP) normalization
|
Chen, Jingyun
|
|
2018
|
45 |
Suppl 1 |
p. 1596-1604
|
artikel
|
| 58 |
223Ra-Dichloride in castration-resistant metastatic prostate cancer: improving outcomes and identifying predictors of survival in clinical practice
|
Dizdarevic, Sabina
|
|
2018
|
45 |
Suppl 1 |
p. 2264-2273
|
artikel
|
| 59 |
Response to neoadjuvant chemotherapy for breast cancer judged by PERCIST – multicenter study in Japan
|
Kitajima, Kazuhiro
|
|
2018
|
45 |
Suppl 1 |
p. 1661-1671
|
artikel
|
| 60 |
Superiority of 68Ga-DOTATATE over 18F-FDG and anatomic imaging in the detection of succinate dehydrogenase mutation (SDHx)-related pheochromocytoma and paraganglioma in the pediatric population
|
Jha, Abhishek
|
|
2017
|
45 |
Suppl 1 |
p. 787-797
|
artikel
|
| 61 |
Targeting angiogenesis for radioimmunotherapy with a 177Lu-labeled antibody
|
Ehlerding, Emily B.
|
|
2017
|
45 |
Suppl 1 |
p. 123-131
|
artikel
|
| 62 |
Texture analysis of high-resolution dedicated breast 18F-FDG PET images correlates with immunohistochemical factors and subtype of breast cancer
|
Moscoso, Alexis
|
|
2017
|
45 |
Suppl 1 |
p. 196-206
|
artikel
|
| 63 |
The role of FDG PET/CT in therapy control of aortic graft infection
|
Husmann, Lars
|
|
2018
|
45 |
Suppl 1 |
p. 1987-1997
|
artikel
|
| 64 |
The roles of 11C-acetate PET/CT in predicting tumor differentiation and survival in patients with cerebral glioma
|
Kim, Soyoung
|
|
2018
|
45 |
Suppl 1 |
p. 1012-1020
|
artikel
|
| 65 |
Trifunctional PSMA-targeting constructs for prostate cancer with unprecedented localization to LNCaP tumors
|
Kelly, James
|
|
2018
|
45 |
Suppl 1 |
p. 1841-1851
|
artikel
|
| 66 |
Ultra-early response assessment in lymphoma treatment: [18F]FDG PET/MR captures changes in glucose metabolism and cell density within the first 72 hours of treatment
|
Mayerhoefer, Marius E.
|
|
2018
|
45 |
Suppl 1 |
p. 931-940
|
artikel
|
| 67 |
Up-front PET/CT changes treatment intent in patients with head and neck squamous cell carcinoma
|
Rohde, Max
|
|
2017
|
45 |
Suppl 1 |
p. 613-621
|
artikel
|
| 68 |
Use of FET PET in glioblastoma patients undergoing neurooncological treatment including tumour-treating fields: initial experience
|
Ceccon, Garry
|
|
2018
|
45 |
Suppl 1 |
p. 1626-1635
|
artikel
|
| 69 |
Visualization of multiple organ amyloid involvement in systemic amyloidosis using 11C-PiB PET imaging
|
Ezawa, Naoki
|
|
2017
|
45 |
Suppl 1 |
p. 452-461
|
artikel
|
| 70 |
89Zr-labeled nivolumab for imaging of T-cell infiltration in a humanized murine model of lung cancer
|
England, Christopher G.
|
|
2017
|
45 |
Suppl 1 |
p. 110-120
|
artikel
|
| 71 |
89Zr-trastuzumab PET supports clinical decision making in breast cancer patients, when HER2 status cannot be determined by standard work up
|
Bensch, Frederike
|
|
2018
|
45 |
Suppl 1 |
p. 2300-2306
|
artikel
|
Tijdschrift beschrijving